Pillstats
Rx only · Injection, Suspension · Intralesional

Methylprednisolone Acetate

Brands: Depo-Medrol · Methylprednisolone Acetate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD07AA01
RxCUI (US)6902
US makers3 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.43$6.86$10.29$13.72Apr 2025Mar 2026Jul 2026
$8.607
Latest avg · Jul 22, 2026
-20%
Since Apr 23, 2025
3
Active US suppliers
88%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

40K80K121K161K2025 Q12025 Q22025 Q32025 Q42026 Q1
106K
Rx · 2026 Q1
154K
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pharmacia & Upjohn Company LLCunknown11SUPPLYING
Sandoz Incunknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfiz…

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • Apr 13, 2022
    RECALLRecall (Class II): Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC#…

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • Dec 15, 2021
    SHORTAGEDrug shortage: Methylprednisolone Acetate Injection (Pfizer Inc.)

    Methylprednisolone Acetate Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.

  • Jul 30, 2014
    RECALLRecall (Class III): Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distribu…

    Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0 — Recalling firm: Pfizer Inc. — Nationwide